Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Pliant Therapeutics Inc (NASDAQ: PLRX) was $1.26 for the day, up 5.00% from the previous closing price of $1.2. In other words, the price has increased by $5.00 from its previous closing price. On the day, 1.12 million shares were traded. PLRX stock price reached its highest trading level at $1.27 during the session, while it also had its lowest trading level at $1.18.
Ratios:
Our analysis of PLRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.03 and its Current Ratio is at 11.03. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.23.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 17 ’25 when Coulie Bernard sold 52,419 shares for $11.20 per share. The transaction valued at 587,150 led to the insider holds 430,517 shares of the business.
Cummings Keith Lamont sold 20,148 shares of PLRX for $225,680 on Jan 17 ’25. The Chief Financial Officer now owns 262,608 shares after completing the transaction at $11.20 per share. On Jan 17 ’25, another insider, Hull Hans, who serves as the Chief Business Officer of the company, sold 15,936 shares for $11.20 each. As a result, the insider received 178,501 and left with 211,558 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLRX now has a Market Capitalization of 77346736 and an Enterprise Value of -174262912.
Stock Price History:
The Beta on a monthly basis for PLRX is 1.41, which has changed by -0.8839779 over the last 52 weeks, in comparison to a change of 0.12677538 over the same period for the S&P500. Over the past 52 weeks, PLRX has reached a high of $16.10, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is -10.83%, while the 200-Day Moving Average is calculated to be -82.72%.
Shares Statistics:
PLRX traded an average of 1.15M shares per day over the past three months and 2267680 shares per day over the past ten days. A total of 61.39M shares are outstanding, with a floating share count of 54.04M. Insiders hold about 11.97% of the company’s shares, while institutions hold 86.81% stake in the company. Shares short for PLRX as of 1749772800 were 3364746 with a Short Ratio of 2.93, compared to 1747267200 on 5038014. Therefore, it implies a Short% of Shares Outstanding of 3364746 and a Short% of Float of 5.6199998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Current recommendations for the stock of the company come from 9.0 analysts. The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.36 and low estimates of -$0.57.
Analysts are recommending an EPS of between -$2.08 and -$2.89 for the fiscal current year, implying an average EPS of -$2.47. EPS for the following year is -$2.39, with 10.0 analysts recommending between -$0.71 and -$6.64.
